| Sep 25 |
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
|
| Aug 7 |
CENTOGENE Receives Delisting Notice From Nasdaq
|
| Aug 1 |
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
|
| May 31 |
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
|
| May 14 |
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
|
| May 10 |
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
|
